Heartware International's (HTWR) Valtech Cardio Acquisition Doesn't Make Sense, Says Northland
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/22/2026
- Nasdaq reaches record high close, AI stocks rally
- Meta AI agent triggers heavy selloff in banks, insurers, and travel stocks
- Exclusive: SB Energy Nasdaq IPO moving forward as planned
- AI and earnings keep driving markets as focus shifts to Trump-Xi summit
- Meta bull case increasingly playing out, Mizuho says
- Pennsylvania measles cases near 800 as outbreak grows
- A timeline of Trump administration moves to weaken endangered species protections
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- SpaceX and Tesla’s AI linkup is getting deeper. Here’s what Morgan Stanley sees
Canaccord Genuity Remains Bullish on Heartware (HTWR) Following Agreement to Acquire Valtech Cardio
September 2, 2015 9:32 AM EDTCanaccord Genuity maintained a Buy rating and $106.00 price target on Heartware Int'l (NASDAQ: HTWR) following the company's agreement to acquire privately held Valtech Cardio. Analyst Jason Mills said that this is the type of deal to which investors commonly overreact; but once the dust settles, he would be a buyer of this stock.
Mills commented, "HeartWares agreement to acquire... More
Raymond James Downgrades Heartware (HTWR) to Market Perform
September 2, 2015 8:36 AM EDTRaymond James downgraded Heartware Int'l (NASDAQ: HTWR) from Outperform to Market Perform and removed its price target (prior $102.00).
For an analyst ratings summary and ratings history on Heartware Int'l click here. For more ratings news on Heartware Int'l click here.
Shares of Heartware Int'l closed at $81.81 yesterday.
... MoreBTIG Downgrades Heartware Int'l (HTWR) to Neutral
September 2, 2015 8:13 AM EDTBTIG downgraded Heartware Int'l (NASDAQ: HTWR) from Buy to Neutral. The change follows its acquisition of Valtech.
"While we understand the rationale of this acquisition and it may prove to be a strong asset over the next 3-5 years, we anticipate there... More
Heartware (HTWR) to Acquire Valtech Cardio
September 1, 2015 4:25 PM EDTHeartware (NASDAQ: HTWR) announced today that it has entered into a definitive agreement to acquire Valtech Cardio, Ltd. ("Valtech"). Valtech is a privately held company that specializes in the development of innovative surgical and transcatheter valve repair and replacement devices for the treatment of the most prevalent heart valve diseases mitral valve regurgitation (MR) and... More
